These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 12019683)

  • 1. The International Commission on Occupational Health (ICOH) and its influence on international organizations.
    Ashford NA; Castleman B; Frank AL; Giannasi F; Goldman LR; Greenberg M; Huff J; Joshi KT; LaDou J; Lemen RA; Maltoni C; O'Neil R; Richter E; Silbergeld EK; Teitelbaum DT; Thebaud-Mony A; Tomatis L; Watterson A
    Int J Occup Environ Health; 2002; 8(2):156-62. PubMed ID: 12019683
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lead IARC towards compliance with WHO/IARC Declaration of Interests (DOI) policy.
    Sass J
    Int J Occup Environ Health; 2002; 8(3):277-8. PubMed ID: 12358083
    [No Abstract]   [Full Text] [Related]  

  • 3. Centennial Declaration of the International Commission on Occupational Health, ICOH.
    Rantanen J; Foà V; Facci R; Cantineau A; Iavicoli S; Bertazzi PA
    Med Lav; 2006; 97(6):810-1. PubMed ID: 17219772
    [No Abstract]   [Full Text] [Related]  

  • 4. ICOH caught in the act. International Commission on Occupational Health.
    LaDou J
    Arch Environ Health; 1998; 53(4):247-8. PubMed ID: 9709987
    [No Abstract]   [Full Text] [Related]  

  • 5. The asbestos cancer epidemic.
    LaDou J
    Environ Health Perspect; 2004 Mar; 112(3):285-90. PubMed ID: 14998741
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pesticide health and safety and the work and impact of international agencies: partial successes and major failures.
    Watterson A
    Int J Occup Environ Health; 2001; 7(4):339-47. PubMed ID: 11783864
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Controversies at international organizations over asbestos industry influence.
    Castleman BI
    Int J Health Serv; 2001; 31(1):193-202. PubMed ID: 11271644
    [TBL] [Abstract][Full Text] [Related]  

  • 8. International occupational health.
    LaDou J
    Int J Hyg Environ Health; 2003 Aug; 206(4-5):303-13. PubMed ID: 12971685
    [TBL] [Abstract][Full Text] [Related]  

  • 9. FIOH-sponsored newsletter misrepresents asbestos hazards in Zimbabwe.
    Bailar JC; Ballal SG; Boback M; Castleman B; Chee HL; Cherniack M; Christiani D; Cicolella A; Fernández de D'Pool J; Egilman D; Frank AL; Garcia MA; Giannasi F; Greenberg M; Harrison RJ; Huff J; Infante P; de Souza EJ; Joshi TK; Kamuzora P; Kazan-Allen L; Kern DG; Kromhout H; Kuswadji S; LaDou J; Lemen RA; Levenstein C; Luethje B; Mancini F; Meel BL; Mekonnen Y; Mendes R; Murie F; Myers J; O'Neill R; Osaro E; Paek D; Richter E; Robertson E; Samuels SW; Soskolne CL; Stuckey R; Teitelbaum DT; Terracini B; Thébaud-Mony A; Vanhoorne M; Wang X; Watterson A; Wedeen R
    Int J Occup Environ Health; 2006; 12(3):254-8. PubMed ID: 16967833
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The safety of many significant chemicals to which humans may be exposed.
    Jacobson MF; Clapp R; Legator M; Lijinsky W; Reuber MD
    Int J Occup Environ Health; 2002; 8(3):279-80. PubMed ID: 12358084
    [No Abstract]   [Full Text] [Related]  

  • 11. Industry influence on occupational and environmental public health.
    Huff J
    Int J Occup Environ Health; 2007; 13(1):107-17. PubMed ID: 17427355
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Re: Implementation of WHO Guidelines on Disclosure of Interest by members of WHO Expert Panels.
    Axelson O; Castleman B; Epstein S; Franco G; Giannasi F; Grandjean P; Greenberg M; Hooper K; Huff J; Jacobson M; Joshi TK; Kulkarni GK; LaDou J; Mazaheri M; Mekonnen Y; Melnick R; Mirabelli D; Ofrin R; Partanen T; Pott F; Sass J; Soskolne CL; Suplido ML; Terracini B; Tomatis L; Ungvary G; Watterson A; Wesseling C; Yassi A
    Int J Occup Environ Health; 2002; 8(3):271-3. PubMed ID: 12358082
    [No Abstract]   [Full Text] [Related]  

  • 13. Re: concern that working group members who will be assessing styrene have financial conflicts of interest.
    Sass JB; Greer L
    Int J Occup Environ Health; 2002; 8(2):153-5. PubMed ID: 12019682
    [No Abstract]   [Full Text] [Related]  

  • 14. Biomonitoring for occupational health risk assessment (BOHRA).
    Manno M; Viau C; ; Cocker J; Colosio C; Lowry L; Mutti A; Nordberg M; Wang S
    Toxicol Lett; 2010 Jan; 192(1):3-16. PubMed ID: 19446015
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ILO to promote global asbestos ban.
    O'Neill R
    New Solut; 2006; 16(4):449-53. PubMed ID: 17317641
    [TBL] [Abstract][Full Text] [Related]  

  • 16. IARC monographs, industry influence, and upgrading, downgrading, and under-grading chemicals: a personal point of view. International Agency for Research on Cancer.
    Huff J
    Int J Occup Environ Health; 2002; 8(3):249-70. PubMed ID: 12358081
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IARC in the dock over ties with asbestos industry.
    Holmes D
    Lancet; 2013 Feb; 381(9864):359-61. PubMed ID: 23383412
    [No Abstract]   [Full Text] [Related]  

  • 18. Industry influences IARC carcinogenesis evaluations.
    Huff J
    Int J Occup Environ Health; 2003; 9(1):83-4. PubMed ID: 16304740
    [No Abstract]   [Full Text] [Related]  

  • 19. [Summary of the 30th Conference of the International Commission of Occupational Health (ICOH) Cancun, Mexico 2012].
    Moshe S
    Harefuah; 2013 Jul; 152(7):419-20. PubMed ID: 23957090
    [No Abstract]   [Full Text] [Related]  

  • 20. IARC and the DEHP quagmire.
    Huff J
    Int J Occup Environ Health; 2003; 9(4):402-4. PubMed ID: 14664499
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.